Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

7

Revenue 2017

Prevnar 13

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Prevnar 13 was produced by Pfizer.

Teva reaches proposed $4.25bn agreement to settle US opioid lawsuits

Teva reaches proposed $4.25bn agreement to settle US opioid lawsuits The Israel-based company said the agreement is with US states, Native American tribes and local plaintiffs, with the payment spread over 13 years.

GSK’s consumer health spin-off Haleon starts trading with £31bn market valuation

GSK’s consumer health spin-off Haleon starts trading with £31bn market valuation GSK shareholders hold around 54.5% of Haleon, while the spin-out continues to hold a 13.5% share.

Sanofi and Regeneron announce positive phase 3 trial results for eosinophilic oesophagi in children under 12

Sanofi and Regeneron announce positive phase 3 trial results for eosinophilic oesophagi in children under 12 Dupixent is a fully human monoclonal antibody that inhibits the signalling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways.

GSK creates new consumer healthcare business, Haleon

GSK creates new consumer healthcare business, Haleon Following the split, at least 54.5% of Haleon will be held by GSK shareholders, 13.5% by GSK itself and 32% by Pfizer.

Roche’s Lunsumio granted Priority Review by FDA for people with relapsed or refractory follicular lymphoma

Roche’s Lunsumio granted Priority Review by FDA for people with relapsed or refractory follicular lymphoma In the US, estimates show around 13, 000 new cases of FL will be diagnosed in 2022.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...